OBJECTIVE	The aim of this study was to evaluate the relative efficacy and safety of zotarolimus-eluting stents ( ZES ) in comparison with the established and widely used sirolimus - ( SES ) and paclitaxel-eluting stents ( PES ) in routine clinical practice .\